FDA Greenlights a CRISPR-Based Test to Diagnose Covid-19
The test gives a result within an hour
Published in
3 min readMay 7, 2020
A test that can diagnose the coronavirus within an hour using the gene-editing technology known as CRISPR has received emergency use authorization from the U.S. Food and Drug Administration.
The test was developed by Sherlock Biosciences, a biotech company launched in March 2019…
